VC firm
Acorn Bioventures
Also known as ACORN BIOVENTURES 2, L.P.
- Investor type
- VC
- Investing status
- Activeas of 2026-09-18Source (opens in a new tab)
- Headquarters
- New York, United States
- Assets under management
- $355MForm ADV private fund GAV, as of 2026-03-19Source (opens in a new tab)
- Latest fund size
- $195MForm ADV gross asset value, as of 2021Source (opens in a new tab)
- Funds
- 2
- Legal name
- ACORN CAPITAL ADVISORS, LLC
Claim, correct or request removal
Record updated 30 September 2026
About
Acorn Bioventures invests across stages in small-cap public and private biotechnology companies focused on bringing novel innovative medicines to patients.
Investment approach
- Thesis
- Our investment process is based on fundamental research. We look for paradigm changing medical therapies, undiscovered or underappreciated assets, backed by outstanding teams.Source (opens in a new tab)
- Takes board seats
- Yes
- Board policy
- service on more than a thirty Boards
- Investing status notes
- Acorn Bioventures invests across stages in small-cap public and private biotechnology companies
Funds
- ACORN BIOVENTURES 2, L.P.
- Vintage 2021Main fund
- ACORN BIOVENTURES, L.P.
- Main fund
SEC registration
- Registered adviser
- ACORN CAPITAL ADVISORS, LLC
- CRD number
- 304164 (opens in a new tab)
- SEC file number
- 801-120833
- Registration
- SEC registered
- Regulatory AUM
- $355Mas of 2026-03-19
- Private funds reported
- 2
- Principal office
- NEW YORK, NY, United States
- SEC CIK
- 1876405
Locations
- Headquarters
- New York, United States
Loading relationship preview